Associate Director
Astex Pharmaceuticals, United Kingdom
Pravin Mahajan is an Associate Director within the Molecular Sciences group at Astex Pharmaceuticals. The company uses a fragment-based screening approach, which employs X-ray crystallography and a range of additional biophysical methods such as NMR, SPR, ITC and DSF to identify hits and optimize leads. Pravin brings extensive expertise in protein expression, purification, and characterization to his role, particularly in the context of structural (X-ray crystallography and cryo-EM) and biophysical techniques.
Prior to joining Astex, he worked at the Structural Genomics Consortium, University of Oxford, where he developed a high-throughput protein expression platform using the BacMam system and made a significant contribution to increasing the throughput of the baculovirus expression vector system.
Production and Biophysical Characterisation of Recombinant Proteins for FBDD
Thursday, May 25, 2023
15:00 – 15:30 CET